Scotland’s First Minister, Nicola Sturgeon opened ReproCell’s European Headquarters in Glasgow. The new headquarters will allow ReproCell to generate new employment opportunities in Scotland whilst strengthening targeted drug discovery and translational research. To read the full article, click here.
£1million investment has been secured by The University of Glasgow to develop treatment for tendon injuries. 1 in 10 people are affected with tendon injuries in their lifetime through sporting injuries, repetitive strain or major traumas. Causeway Therapeutics work to develop therapies for tendon injuries and discovered a single microRNA that plays a key role in strengthening tendons. To read the full article, click here.
Scottish bio-tech company has been awarded €4million to develop its pioneering cancer treatment. This is the largest EU award to any Scottish company for healthcare therapeutic product. The recipients of the award, TC BioPharm(TCB) announced the investment which will aide in their development of GTD cell therapy treatment for cancer. The research will allow the therapeutic cells derived from a single donor to treat several...